Company

Novo Nordisk

Danish pharmaceutical company and maker of Ozempic and Wegovy semaglutide drugs for diabetes and weight loss

Healthcare & Biotech

News

Interviews (1)

TJ Parker: Hims' compounded GLP-1 pill is a 'financial hail Mary' with no evidence it works — and Trump Rx is the real deal
6 Feb 2026

News (2)

Eli Lilly hits $1T market cap — the first pharma company ever to do so
21 Nov 2025
Hims & Hers stock crashes 32% after Novo Nordisk terminates partnership over alleged GLP-1 knockoff sales
24 Jun 2025